Genetic Signatures (ASX:GSS)

ASX announcement history & article coverage

22
Total announcements
(in last 3 months)
5
With article
17
No article
Article coverage
23%
Transparent by design. Announcments by Genetic Signatures (ASX:GSS) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.

3 Sept 2026 · 09:37 am AEST ⚡ Price SensitiveMaterialUnexpected ASX Filing
BDX Holdings of GSS Shares and receipt of Section 249D
Genetic Signatures questions BCAL Diagnostics shareholding and receives director removal notice
1 Sept 2026 · 12:12 pm AEST ASX Filing
Final Director's Interest Notice

31 Aug 2026 · 08:39 am AEST ASX Filing
Board Changes
27 Aug 2026 · 04:24 pm AEST ASX Filing
Ceasing to be a substantial holder
26 Aug 2026 · 09:30 am AEST ⚡ Price SensitiveMaterial ASX Filing
Genetic Signatures and Microba in Merger Discussions
Genetic Signatures and Microba Life Sciences in preliminary merger talks to create infectious disease diagnostics leader
26 Aug 2026 · 08:35 am AEST ASX Filing
Change in Substantial Shareholder Notice from BDX
25 Aug 2026 · 02:12 pm AEST ASX Filing
Change in substantial holding
25 Aug 2026 · 09:29 am AEST ASX Filing
FY26 Appendix 4G and Corporate Governance Statement
25 Aug 2026 · 09:25 am AEST ⚡ Price SensitiveMaterial ASX Filing
FY26 Market Update
Genetic Signatures reports FY2026 loss reduction, signs key supply agreements, and outlines growth strategy
25 Aug 2026 · 09:15 am AEST ⚡ Price SensitiveMaterial ASX Filing
FY26 Results Release
Genetic Signatures reports reduced net loss, secures long-term contracts, and outlines growth strategy for FY2027
25 Aug 2026 · 09:09 am AEST ⚡ Price SensitiveMaterial ASX Filing
FY26 Appendix 4E and Annual Report
Genetic Signatures narrows FY2026 loss by 30% amid strategic reset and new EMEA contract
24 Aug 2026 · 10:16 am AEST ASX Filing
FY 26 Annual Results and Investor Webinar Notification
21 Aug 2026 · 09:26 am AEST ASX Filing
Commercial Testing Commences at Hvidovre Hospital in Denmark

23 July 2026 · 02:11 pm AEST ⚡ Price SensitiveMaterial ASX Filing
Quarterly Activities/Appendix 4C Cash Flow Report
Genetic Signatures reports $5M annual cost savings post-restructuring, signs 10-year Danish supply deal, and posts $14.8M FY2026 revenue
2 July 2026 · 05:13 pm AEST ASX Filing
Becoming a substantial holder from BDX
2 July 2026 · 02:41 pm AEST ⚡ Price SensitiveMaterialUnexpected ASX Filing
GSS responds to the BCAL Diagnostics Announcement
Genetic Signatures responds to BCAL share acquisition announcement, confirms no prior knowledge
1 July 2026 · 12:20 pm AEST ASX Filing
Ceasing to be a substantial holder

19 June 2026 · 08:58 am AEST ASX Filing
Change of Company Secretary
18 June 2026 · 04:55 pm AEST ASX Filing
Change in substantial holding
16 June 2026 · 11:24 am AEST ASX Filing
Change in substantial holding
10 June 2026 · 08:24 am AEST ASX Filing
Investor Presentation
9 June 2026 · 08:29 am AEST ASX Filing
Investor Webinar Notification